About Unither
Unither is a Healthcare company based in Paris (France) founded in 1993, and was acquired by Ardian in November 2016. Contract development and manufacturing organization for proprietary and generic drugs. Unither has completed 1 acquisition, including Nanjing Ruinian Best Pharmaceutical. Its focus areas include Biopharma Outsourcing, CDMO, Small Molecules & Peptides and Formulation.
Company details
Founded in 1993 and headquartered in Paris, France, Unither operates as a contract development and manufacturing organization in the pharmaceutical sector. Various dosage forms, including blow-fill seals, liquid and powder stick packs, effervescent tablets, pharmaceutical bottles, suppositories, and pessaries, are produced. RD and manufacturing facilities are maintained in Europe, with an additional manufacturing site in North America and sales offices in Brazil.
- Headquarters Paris, France
- Stage Acquired
- SectorsHealthcare
- Website category Health · Biotechnology and Pharmaceuticals
- Website unither-pharma.com
- Social LinkedIn X YouTube
- Acquired by Ardian (Nov 2016)
- InvestorsIdinvest Partners
& 11 more
- Investments & Acquisitions
- Acquired by
Apps and channels of Unither
its YouTube channel Unither Pharmaceuticals has 442 subscribers and 30 videos.
Videos from Unither
The most watched videos on Unither's YouTube channel, Unither Pharmaceuticals (442 subscribers). Click a video to play it here.
More on Unither Pharmaceuticals.
Funding Insights of Unither
- Total Rounds 7
- Investors Count 10
All 7 funding rounds of Unither with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Oct 2022 | Series C | – | – | ||
| Dec 2021 | $903,720 | Grant | – | – | |
| Mar 2017 | Debt – Conventional | – | – | ||
| Nov 2011 | Debt – Conventional | – | – | ||
| Oct 2011 | Series B | – | Parquest, Picardie Investissement | – | |
| Jun 2006 | Series A | – | – | ||
| Aug 2000 | Series A | – | – |
12 investors in total: 12 institutional.
Investors in Unither
Unither has secured backing from 12 investors, including venture fund and institutional investors. Prominent investors backing the company include Idinvest Partners, IK Partners and GIC.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Sovereign wealth is managed and private equity investments are facilitated. | gic.com.sg | Singapore, Singapore | ||
Private equity investments are directed toward small and medium-sized businesses. | 1989 | ikpartners.com | Amsterdam, Netherlands | |
Equity investments are provided to low and middle market companies. | 1997 | idinvest.com | Paris, France | |
Private investment firm specializing in markets and partnerships. | ardian.com | |||
Private equity investments in France are managed by Parquest. | parquest.fr | Paris, France | ||
Equity investment services are provided to support business growth. | 1985 | picardie-investissement.fr | Amiens, France | |
Growth and acquisition investments are managed by Credit Mutuel Equity. | creditmutuel-equity.eu | Paris, France | ||
CAPZA is recognized as a European private investment platform. | 2004 | capza.co | Paris, France | |
| syntegracapital.com | ||||
A mid-market private equity firm based in Europe is operated. | equistonepe.com | London, United Kingdom |
Investor details for Unither
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Unither
1 people are tracked at Unither (1 in team).
| Name | Role | Group |
|---|---|---|
Unither Pharmaceuticals | Pharmaceuticals | Team |
Complete people profiles for Unither
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Unither
Unither has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Nanjing Ruinian Best Pharmaceutical.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Drug development services are provided in the pharmaceutical sector. | rnbst.com | China | 2009 | Aug 2020 | •••• |
Complete acquisition details for Unither
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of Unither
6 dated milestones of Unither across 29 years, from founding to its latest funding, stage changes and deals.
- Founded Unither is founded.
- Funding First funding round.
- Exit Acquired by Equistone Partners Europe.
- Exit Acquired by Ardian.
- Acquisition Acquires Nanjing Ruinian Best Pharmaceutical.
- Funding Latest funding round, Series C,.
Web traffic of Unither
The website of Unither (unither-pharma.com) receives about 7.7K visits a month and ranks #2,502,555 among all websites worldwide, #3,436 in Biotechnology and Pharmaceuticals.
- Monthly visits7.7K
▼ 9% vs previous month
- Unique visitors3.6K
per month
- Global rank#2,502,555
among all websites
- Category rank#3,436
Health · Biotechnology and Pharmaceuticals
- Bounce rate42%
- Pages per visit1.8
- Average visit52 sec
- DevicesDesktop 34% · Mobile 66%
Websites whose visitors overlap most with Unither. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| unither.com | 100% | 32.2K | #968,866 | View details | |
| auspexpharma.com | 88% | View details | |||
| arenapharm.com | 87% | View details | |||
bionikapharm.com | bionikapharm.com | 54% | – | ||
majorpharmaceuticals.com | majorpharmaceuticals.com | 54% | – |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Unither
Complete news archive for Unither
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Unither
Unither was founded in 1993 and raised its 1st funding round 7 years after it was founded.
Unither is headquartered in Paris, France.
Founded in 1993 and headquartered in Paris, France, Unither operates as a contract development and manufacturing organization in the pharmaceutical sector. Various dosage forms, including blow-fill seals, liquid and powder stick packs, effervescent tablets, pharmaceutical bottles, suppositories, and pessaries, are produced. RD and manufacturing facilities are maintained in Europe, with an additional manufacturing site in North America and sales offices in Brazil.
Unither has made 1 acquisition, including Nanjing Ruinian Best Pharmaceutical.
Unither has 12 investors. Key investors include Idinvest Partners, IK Partners, GIC, Ministry of Economy, Finance and Industrial and Digital Sovereignty, and Ardian.
Yes. Unither was acquired by Ardian in November 2016.